Alex Molassiotis1, Jaclyn A Smith2, Peter Mazzone3, Fiona Blackhall4, Richard S Irwin5. 1. School of Nursing, The Hong Kong Polytechnic University, Hong Kong, China. Electronic address: alex.molasiotis@polyu.edu.hk. 2. Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital of South Manchester, Manchester, England. 3. Respiratory Institute, Cleveland Clinic, Cleveland, OH. 4. Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, England. 5. University of Massachusetts Medical School, Worcester, MA.
Abstract
BACKGROUND: Cough among patients with lung cancer is a common but often undertreated symptom. We used a 2015 Cochrane systematic review, among other sources of evidence, to update the recommendations and suggestions of the American College of Chest Physicians (CHEST) 2006 guideline on this topic. METHODS: The CHEST methodologic guidelines and the Grading of Recommendations, Assessment, Development, and Evaluation framework were used. The Expert Cough Panel based their recommendations on data from the Cochrane systematic review on the topic, uncontrolled studies, case studies, and the clinical context. Final grading was reached by consensus according to the Delphi method. RESULTS: The Cochrane systematic review identified 17 trials of primarily low-quality evidence. Such evidence was related to both nonpharmacologic (cough suppression) and pharmacologic (demulcents, opioids, peripherally acting antitussives, or local anesthetics) treatments, as well as endobronchial brachytherapy. CONCLUSIONS: Compared with the 2006 CHEST Cough Guideline, the current recommendations and suggestions are more specific and follow a step-up approach to the management of cough among patients with lung cancer, acknowledging the low-quality evidence in the field and the urgent need to develop more effective, evidence-based interventions through high-quality research.
BACKGROUND:Cough among patients with lung cancer is a common but often undertreated symptom. We used a 2015 Cochrane systematic review, among other sources of evidence, to update the recommendations and suggestions of the American College of Chest Physicians (CHEST) 2006 guideline on this topic. METHODS: The CHEST methodologic guidelines and the Grading of Recommendations, Assessment, Development, and Evaluation framework were used. The Expert Cough Panel based their recommendations on data from the Cochrane systematic review on the topic, uncontrolled studies, case studies, and the clinical context. Final grading was reached by consensus according to the Delphi method. RESULTS: The Cochrane systematic review identified 17 trials of primarily low-quality evidence. Such evidence was related to both nonpharmacologic (cough suppression) and pharmacologic (demulcents, opioids, peripherally acting antitussives, or local anesthetics) treatments, as well as endobronchial brachytherapy. CONCLUSIONS: Compared with the 2006 CHESTCough Guideline, the current recommendations and suggestions are more specific and follow a step-up approach to the management of cough among patients with lung cancer, acknowledging the low-quality evidence in the field and the urgent need to develop more effective, evidence-based interventions through high-quality research.
Authors: Katharine A Dobson Amato; Andrew Hyland; Robert Reed; Martin C Mahoney; James Marshall; Gary Giovino; Maansi Bansal-Travers; Heather M Ochs-Balcom; Michael A Zevon; K Michael Cummings; Chukwumere Nwogu; Anurag K Singh; Hongbin Chen; Graham W Warren; Mary Reid Journal: J Thorac Oncol Date: 2015-07 Impact factor: 15.609
Authors: Ping Yang; Andrea L Cheville; Jason A Wampfler; Yolanda I Garces; Aminah Jatoi; Matthew M Clark; Stephen D Cassivi; David E Midthun; Randolph S Marks; Marie-Christine Aubry; Scott H Okuno; Brent A Williams; Francis C Nichols; Victor F Trastek; Hiroshi Sugimura; Linda Sarna; Mark S Allen; Claude Deschamps; Jeff A Sloan Journal: J Thorac Oncol Date: 2012-01 Impact factor: 15.609
Authors: Amelie S M Harle; Fiona H Blackhall; Jacky A Smith; Alexander Molassiotis Journal: Curr Opin Support Palliat Care Date: 2012-06 Impact factor: 2.302
Authors: Alex Molassiotis; Jackie Ellis; Richard Wagland; Mari Lloyd Williams; Chris D Bailey; Richard Booton; Fiona Blackhall; Janelle Yorke; Jaclyn A Smith Journal: J Pain Symptom Manage Date: 2012-08-25 Impact factor: 3.612
Authors: Kian Fan Chung; Lorcan McGarvey; Woo-Jung Song; Anne B Chang; Kefang Lai; Brendan J Canning; Surinder S Birring; Jaclyn A Smith; Stuart B Mazzone Journal: Nat Rev Dis Primers Date: 2022-06-30 Impact factor: 65.038
Authors: Seonkyeong Yang; Juan M Hincapie-Castillo; Xuehua Ke; Jonathan Schelfhout; Helen Ding; Mandel R Sher; Lili Zhou; Ching-Yuan Chang; Debbie L Wilson; Wei-Hsuan Lo-Ciganic Journal: J Clin Med Date: 2022-06-25 Impact factor: 4.964
Authors: Nicole L Stout; Daniel Santa Mina; Kathleen D Lyons; Karen Robb; Julie K Silver Journal: CA Cancer J Clin Date: 2020-10-27 Impact factor: 508.702
Authors: Amélie Harle; Alex Molassiotis; Oliver Buffin; Jack Burnham; Jaclyn Smith; Janelle Yorke; Fiona H Blackhall Journal: BMC Cancer Date: 2020-01-06 Impact factor: 4.430
Authors: Alex Molassiotis; Anne Fraser; Melissa Culligan; Pippa Labuc; Degi L Csaba; Andreas Charalambous Journal: Front Oncol Date: 2020-10-26 Impact factor: 6.244